Ernexa Therapeutics Analyst Price Targets

Ernexa Therapeutics Inc

ERNANASDAQ

$2.11

0.136.57%

Últ. Act.: Oct 29, 9:06 AM

Ernexa Therapeutics Analyst Price Targets - Benzinga

Wall Street analyst price targets and consensus rating for Ernexa Therapeutics (ERNA).

Price Target Range — 1 Quarters

Analyst Consensus — 1 Analysts

1Buy

Consensus RatingBuy# Analysts1Avg. Consensus PT$30Upside to Avg. PT+1392.5%

Rating Trend — Last 9 Months

Date	Firm	Analyst	Action	Rating Change	Price Target
May 7, 2026	Brookline Capital	—	Initiate	Buy	$30

Benzinga Newsdesk